Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Concerns About Diagnosing Hypertension in the Emergency Department-Reply.

JAMA cardiology·2025
Same author

Emergency Department-Based Education and mHealth Empowerment Intervention for Hypertension: The TOUCHED Randomized Clinical Trial.

JAMA cardiology·2025
Same author

Association of Clonal Hematopoiesis of Indeterminate Potential with Cardiovascular Events in Patients with CKD.

Journal of the American Society of Nephrology : JASN·2025
Same author

Rationale for a New Low-Dose Triple Single Pill Combination for the Treatment of Hypertension.

Global heart·2024
Same author

A machine learning approach identifies modulators of heart failure hospitalization prevention among patients with type 2 diabetes: A revisit to the ACCORD trial.

Journal of diabetes and its complications·2022
Same author

Authors' Reply.

The Journal of molecular diagnostics : JMD·2022
Same journal

Antihypertensive Efficacy, Safety, and Adherence After Switching From a Free Combination of Bisoprolol/Metoprolol and Amlodipine to Bisoprolol/Amlodipine FDC Tablets (5/5 mg) in Chinese Patients With Hypertension.

Journal of clinical hypertension (Greenwich, Conn.)·2026
Same journal

Blood Pressure Variability in Acute Ischemic Stroke: Current Evidence, Measurement Challenges, and Future Directions.

Journal of clinical hypertension (Greenwich, Conn.)·2026
Same journal

Association of Triglyceride-Glucose Index, Triglyceride/HDL Cholesterol Ratio and Metabolic Score for Insulin Resistance With Asymptomatic Organ Damage in Previously Untreated Patients With Hypertension.

Journal of clinical hypertension (Greenwich, Conn.)·2026
Same journal

Letter to the Editor Regarding: "Associations of High-Sensitivity Cardiac Troponin and N-Terminal Pro-B-Type Natriuretic Peptide With Echocardiographic Features in Patients With Hypertension".

Journal of clinical hypertension (Greenwich, Conn.)·2026
Same journal

Relationship of Carotid-Femoral Pulse Wave Velocity and Brachial-Ankle Pulse Wave Velocity With the Risk of New-Onset Cardiovascular Events: A Cohort Study in the Beijing Community-Based Population.

Journal of clinical hypertension (Greenwich, Conn.)·2026
Same journal

Oral Health and Cardiovascular Disease Among Hypertensive Medicated Adults With Uncontrolled Blood Pressure.

Journal of clinical hypertension (Greenwich, Conn.)·2026
See all related articles

Related Experiment Videos

Thiazide and loop diuretics.

Domenic A Sica1, Barry Carter, William Cushman

  • 1Department of Medicine, Section of Clinical Pharmacology and Hypertension, Virginia Commonwealth University Health System, MCV Station, Richmond, VA, USA. dsica@mcvh-vcu.edu

Journal of Clinical Hypertension (Greenwich, Conn.)
|September 8, 2011
PubMed
Summary
This summary is machine-generated.

Chlorthalidone is a potent thiazide diuretic effective for hypertension, offering significant benefits over hydrochlorothiazide. It demonstrates comparable outcomes to other antihypertensives in major trials and is a cost-effective first-line treatment for reducing cardiovascular mortality and morbidity.

Related Experiment Videos

Area of Science:

  • Pharmacology and Therapeutics
  • Cardiovascular Medicine
  • Nephrology

Background:

  • Chlorthalidone and hydrochlorothiazide, though structurally similar thiazide diuretics, exhibit distinct pharmacokinetic profiles, with chlorthalidone possessing a longer half-life and gradual elimination.
  • Loop diuretics, such as furosemide, are widely used but characterized by highly variable oral absorption.
  • Certain patient populations, including Black individuals, the elderly, and those with diabetes or metabolic syndrome, often show a greater response to thiazide diuretics.

Purpose of the Study:

  • To compare the pharmacokinetic and pharmacodynamic properties of chlorthalidone and hydrochlorothiazide.
  • To evaluate the efficacy and safety of chlorthalidone compared to other antihypertensive agents in large-scale clinical trials.
  • To provide practical recommendations for the optimal use of diuretics in hypertension management.

Main Methods:

  • Pharmacokinetic analysis comparing half-life and volume of distribution.
  • Review of major clinical trials, including ALLHAT and ACCOMPLISH, assessing cardiovascular outcomes.
  • Analysis of adverse event profiles and drug interactions associated with thiazide and loop diuretics.

Main Results:

  • Chlorthalidone (25 mg) is more potent than hydrochlorothiazide (50 mg), particularly in reducing overnight blood pressure.
  • The ALLHAT study found no significant differences in primary outcomes or mortality between chlorthalidone and amlodipine, lisinopril, or doxazosin, though secondary outcomes varied.
  • Thiazide diuretics are effective first-line agents for hypertension, reducing cardiovascular morbidity and mortality cost-effectively, while loop diuretics are best reserved for fluid overload or renal failure.

Conclusions:

  • Chlorthalidone is a highly effective and cost-efficient first-line antihypertensive agent with a favorable long-term outcome profile.
  • Understanding the pharmacokinetic differences and specific patient responses to diuretics is crucial for optimizing hypertension treatment.
  • Careful consideration of potential adverse effects and drug interactions is necessary when using diuretics, particularly in combination therapies.